AGNCZ Q1 2026 Earnings EPS Surpasses Estimates with 145 Beat Preferred Shares Edge Higher HOVR Q1 2026 Earnings WiderThanExpected Loss as Development Continues Stock Surges Over 26 MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline NovaBridge Biosciences NBP Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 508 BTU Q1 2026 Earnings Disappointing EPS Miss Highlights Headwinds in Coal Markets